Column Group II GP, LP

10% owner at IMMUNE DESIGN CORP. · on record since Sep 22, 2016
10% owner at Arcus Biosciences, Inc. · on record since Mar 19, 2018
general partner at Gritstone bio, Inc. · on record since Sep 27, 2018
10% owner at RAPTOR TECHNOLOGY GROUP, INC. · on record since Sep 29, 2021
10% owner at eFFECTOR Therapeutics, Inc. · on record since Sep 7, 2021
10% owner at Oric Pharmaceuticals, Inc. · on record since Nov 16, 2021
10% owner at NGM BIOPHARMACEUTICALS INC · on record since Jan 26, 2022
Insider at NGM BIOPHARMACEUTICALS INC · on record since Jan 25, 2023

Insider trading activity of Column Group II GP, LP

Transactions on record: 10; since Sep 22, 2016

Open-market buys: 10; $7.6M

Open-market sells: 0

Companies traded: 2; last filing Jan 23, 2023

Figures computed from official regulatory filings — .

Companies where Column Group II GP, LP has traded

NGM BIOPHARMACEUTICALS INC9 tx · $2.6M · Jan 23, 2023
IMMUNE DESIGN CORP.1 tx · $5M · Sep 22, 2016

Track record of Column Group II GP, LP

Open-market buys: 10

Last buy: Jan 20, 2023

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of Column Group II GP, LP

Co-insiders of Column Group II GP, LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 23, 2023	Buy	37,639	5.00 USD	$188.2K	conv 37ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 23, 2023	Buy	500	5.00 USD	$2.5K	conv 23Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Aug 17, 2020	Buy	37,993	17.49 USD	$664.5K	conv 23Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Aug 17, 2020	Buy	6,425	17.89 USD	$114.9K	conv 23Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Aug 17, 2020	Buy	19,895	17.89 USD	$355.9K	conv 23Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Aug 3, 2020	Buy	732	17.99 USD	$13.2K	conv 35ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jul 15, 2019	Buy	10,870	13.87 USD	$150.8K	conv 33Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jul 15, 2019	Buy	21,014	13.88 USD	$291.7K	conv 23Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 9, 2019	Buy	57,000	14.10 USD	$803.7K	conv 48ClusterFirst in 12mo	SEC
IMMUNE DESIGN CORP.Listing unverified	Sep 22, 2016	Buy	800,000	6.25 USD	$5M	conv 52ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 23, 2023	Buy	37,639	5.00 USD	$188.2K	conv 37ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jan 23, 2023	Buy	500	5.00 USD	$2.5K	conv 23Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Aug 17, 2020	Buy	37,993	17.49 USD	$664.5K	conv 23Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Aug 17, 2020	Buy	6,425	17.89 USD	$114.9K	conv 23Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Aug 17, 2020	Buy	19,895	17.89 USD	$355.9K	conv 23Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Aug 3, 2020	Buy	732	17.99 USD	$13.2K	conv 35ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jul 15, 2019	Buy	10,870	13.87 USD	$150.8K	conv 33Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Jul 15, 2019	Buy	21,014	13.88 USD	$291.7K	conv 23Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 9, 2019	Buy	57,000	14.10 USD	$803.7K	conv 48ClusterFirst in 12mo	SEC
IMMUNE DESIGN CORP.Listing unverified	Sep 22, 2016	Buy	800,000	6.25 USD	$5M	conv 52ClusterFirst in 12mo	SEC